• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Commentary: Use of a Disposable Radiation Protective Table for Reducing Operator Radiation

  • Fri, 9/5/08 - 3:36pm
  • 0 Comments
  • 1908 reads
Author(s): 

Daniel Clair, MD

The EPics 1 study reported by Dall’Olmo et al,1 in this issue of Vascular Disease Management reports on one surgical group’s evaluation of patients age 60 and older, both male and female, with a history of surgical, coronary revascularization invited to participate in an abdominal aortic aneurysm (AAA) screening program. The authors identified aneurysms in 9% of males screened and 5% of females screened with the majority of these in both groups having been previously unrecognized. This study is important in that it confirms the presence of increased risk for the presence of AAA in a defined population with clinically significant coronary disease, and notes the presence of this problem in males and females.

The recently implemented SAAAVE Act (Screening Abdominal Aortic Aneurysms Very Efficiently Act, a provision of S. 1932, the Deficit Reduction Act of 2005) allows a one time ultrasound screening benefit to check for AAA in Medicare beneficiaries who are “at risk”. The population defined as being at risk includes men who have at least a 100-pack year smoking history and men and women with a family history of AAA. While we applaud this Act for subsidizing screening of patients at risk for AAA, there are clearly other groups of patients who are at high risk that are not addressed with this coverage. Additionally, large, population-based trials that have implemented screening among the elderly without regard to “risk” have clearly shown benefit in reducing aneurysm related deaths among screening participants.2,3

In assessing patients with coronary artery disease (CAD), the authors of the current study have identified a high-risk group of patients who clearly would benefit from screening. This increased risk affects both males and females with a history of CAD who have undergone surgical revascularization. Understanding the propensity for atherosclerosis to have systemic effects upon those afflicted, it would appear likely that atherosclerotic disease in other vascular beds would put patients at increased risk for the development of abdominal aortic aneurysm as well. Screening studies such as these are to be applauded as they provide additional data to physicians and legislators alike regarding the need to expand coverage for AAA screening in the Medicare population.

We look forward to more information regarding these increased risk groups to provide evidence for expansion of this coverage.

References: 

1. Dall’Olmo C, IppolitoAL, McIlduff J, et al. EPics I Study: Evaluation of possible abdominal aortic aneurysms (In patients who have undergone previous CABG). Vascular Disease Management 2007;4:16–20.
2. Thompson S, Kim L, Scott A, Screening for abdominal aortic aneurysm. Screening reduces deaths related to aneurysm. BMJ 2005;330:601.
3. Takagi H, Tanabashi T, Kawai N, et al. Abdominal aortic aneurysm screening reduces mortality: Metanalyses of randomized, controlled trials. Eur J Vasc Endovasc Surg 2007;33:132–133.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
  • Robotic-Assisted Pci Procedures Using Corpath 200 System Will Be Discussed During CRT2012 Conference
    Tue, 02/07/12 - 10:00am
  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications